🇺🇸 FDA
Patent

US 8324181

Modulation of gene expression by oligomers targeted to chromosomal DNA

granted A61KA61K48/005

Quick answer

US patent 8324181 (Modulation of gene expression by oligomers targeted to chromosomal DNA) held by The Board of Regents of the University of Texas System expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K48/005